Widespread and Frequent Testing is Essential to Controlling Coronavirus Disease 2019 (COVID-19) in the United States

Eli S Rosenberg^{1

2}, David R Holtgrave^{2

3}

Affiliations

¹ Department of Epidemiology and Biostatistics, University at Albany School of Public Health, State University of New York, Rensselaer, New York, USA.
² Center for Collaborative Human Immunodeficiency Virus (HIV) Research in Practice and Policy, University at Albany School of Public Health, State University of New York, Rensselaer, New York, USA.
³ Department of Health Policy, Management, and Behavior, University at Albany School of Public Health, State University of New York, Rensselaer, New York, USA.

Editorial

Eli S Rosenberg et al. Clin Infect Dis. 2021.

. 2021 Nov 2;73(9):e2918-e2920.

doi: 10.1093/cid/ciaa1508.

Eli S Rosenberg^{1

2}, David R Holtgrave^{2

3}

¹ Department of Epidemiology and Biostatistics, University at Albany School of Public Health, State University of New York, Rensselaer, New York, USA.
² Center for Collaborative Human Immunodeficiency Virus (HIV) Research in Practice and Policy, University at Albany School of Public Health, State University of New York, Rensselaer, New York, USA.
³ Department of Health Policy, Management, and Behavior, University at Albany School of Public Health, State University of New York, Rensselaer, New York, USA.

No abstract available

Keywords: COVID-19; cost-effectiveness; model; testing.

Comment on

Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts.
Neilan AM, Losina E, Bangs AC, Flanagan C, Panella C, Eskibozkurt GE, Mohareb A, Hyle EP, Scott JA, Weinstein MC, Siedner MJ, Reddy KP, Harling G, Freedberg KA, Shebl FM, Kazemian P, Ciaranello AL. Neilan AM, et al. Clin Infect Dis. 2021 Nov 2;73(9):e2908-e2917. doi: 10.1093/cid/ciaa1418. Clin Infect Dis. 2021. PMID: 32945845 Free PMC article.